Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 12/20 | 0.54 |
| ▸ | ADH1C | P00326 | 9/20 | 0.52 |
| ▸ | ADH4 | P08319 | 3/20 | 0.50 |
| ▸ | ADH1B | P00325 | 3/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18570188 | 1.00 | ADH1A (0.54) | ADH1AADH1CADH4ADH1BADH7 | |
| SCHEMBL3956369 | 0.97 | — | — | |
| SCHEMBL27719489 | 0.95 | — | — | |
| SCHEMBL27845046 | 0.91 | ADH1A (0.46) | ADH1AADH1CADH4ADH1BADH7 | |
| SCHEMBL2453051 | 0.86 | — | — | |
| SCHEMBL28057896 | 0.75 | ADH1A (0.33) | ADH1AADH1CADH4 | |
| SCHEMBL27121722 | 0.74 | ADH1A (0.37) | ADH1AADH1CADH4ADH1BPHGDH | |
| SCHEMBL28005038 | 0.73 | APLNR (0.38) | ADH1AADH1CADH4ADH1B | |
| SCHEMBL28040278 | 0.73 | APLNR (0.38) | ADH1AADH1CADH4ADH1B | |
| SCHEMBL14855293 | 0.72 | ADH1A (0.94) | ADH1AADH1CADH4ADH1BADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036545-A | Recycled polypropylene toughening modifier and application thereof | 太原科技大学 | 2026-05-15 | — | — | CN | claimed |
| CN-110105355-A | A kind of preparation method of 1,2,3- triazole-[1,5-a] and quinolines | 烟台大学 | 2019-08-09 | — | — | CN | claimed |
| EP-2597955-B1 | QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME | ONCOTHERAPY SCIENCE INC (JP) | 2016-01-20 | — | — | EP | claimed |
| US-9120749-B2 | Quinoline derivatives and MELK inhibitors containing the same | ONCOTHERAPY SCIENCE, INC. (JP) | 2015-09-01 | — | — | US | claimed |
| US-20130217671-A1 | QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME | ONCOTHERAPY SCIENCE, INC. (JP) | 2013-08-22 | — | — | US | claimed |
| US-8013153-B2 | Substituted pyrimidine kinase inhibitors | JANSSEN PHARMACEUTICA, N.V. (BE) | 2011-09-06 | — | — | US | claimed |
| US-20070254896-A1 | SUBSTITUTED PYRIMIDINE KINASE INHIBITORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-11-01 | — | — | US | claimed |
| WO-2007109783-A2 | SUBSTITUTED PYRIMIDINE KINASE INHIBITORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-09-27 | — | — | WO | claimed |
| CN-122036545-A | Recycled polypropylene toughening modifier and application thereof | 太原科技大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-115552235-A | Method for evaluating purity of drug contained in complex and method for producing complex | 东丽株式会社 | 2022-12-30 | — | — | CN | disclosed |
| CN-113562855-A | Environment-friendly efficient boiler water regulator for drum boiler | 浙江砉润科技有限公司 | 2021-10-29 | — | — | CN | disclosed |
| CN-110105355-A | A kind of preparation method of 1,2,3- triazole-[1,5-a] and quinolines | 烟台大学 | 2019-08-09 | — | — | CN | disclosed |
| CN-109642024-A | Active targeting type polymeric derivative, the composition comprising the polymeric derivative and their purposes | 日本化药株式会社 | 2019-04-16 | — | — | CN | disclosed |
| EP-2597955-B1 | QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME | ONCOTHERAPY SCIENCE INC (JP) | 2016-01-20 | — | — | EP | disclosed |
| US-8013153-B2 | Substituted pyrimidine kinase inhibitors | JANSSEN PHARMACEUTICA, N.V. (BE) | 2011-09-06 | — | — | US | disclosed |
| US-20110058244-A1 | ELECTROCHROMIC DISPLAY ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2011-03-10 | — | — | US | disclosed |
| US-20070254896-A1 | SUBSTITUTED PYRIMIDINE KINASE INHIBITORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-11-01 | — | — | US | disclosed |
| WO-2007109783-A2 | SUBSTITUTED PYRIMIDINE KINASE INHIBITORS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-09-27 | — | — | WO | disclosed |
| EP-0947510-B1 | Process for the preparation of 1,3,4-trisubstituted 1,2,4-triazolium salts | BASF AG (DE) | 2002-02-13 | — | — | EP | disclosed |
| EP-0947510-A1 | Process for the preparation of 1,3,4-trisubstituted 1,2,4-triazolium salts | BASF AKTIENGESELLSCHAFT (DE) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254896-A1 | SUBSTITUTED PYRIMIDINE KINASE INHIBITORS | DTYMK, TK1, DCK | ADH1A 3002/4885ADH1C 3456/4885ADH4 2984/4885 |
| US-20130217671-A1 | QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE SAME | MELK, NADK, NEK1 | ADH1A 3757/4885ADH1C 4443/4885ADH4 2232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.